Valproate-induced hyperammonemic encephalopathy enhanced by topiramate and phenobarbitone: A case report and an update

Although sodium valproate (VPA)-induced hepatic encephalopathy is a well-recognized entity, VPA can occasionally produce encephalopathy secondary to hyperammonemia in the presence of normal hepatic function, namely valproate-induced non-hepatic hyperammonemic encephalopathy (VNHE). Known risk factor...

Descripción completa

Detalles Bibliográficos
Autores principales: Vivekanandan, S., Nayak, S. Dinesh
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2010
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2924516/
https://www.ncbi.nlm.nih.gov/pubmed/20814502
http://dx.doi.org/10.4103/0972-2327.64638

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2924516/
https://www.ncbi.nlm.nih.gov/pubmed/20814502
http://dx.doi.org/10.4103/0972-2327.64638

Ejemplares similares